Results 31 to 40 of about 54,915 (254)

Voriconazole-induced hypokalemia and hyponatremia and their correlations with voriconazole trough concentration

open access: yesDi-san junyi daxue xuebao, 2020
Objective To investigate the incidence rates of voriconazole-induced hypokalemia and hyponatremia and their correlations with voriconazole trough concentration in the patients with lung invasive aspergillosis.
CHENG Lin   +3 more
doaj   +1 more source

Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit

open access: yesInternational Journal of Infectious Diseases, 2017
Objective: To examine the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit (ICU) and to analyze the factors influencing the trough concentration.
Xiaodan Qian   +4 more
doaj   +1 more source

Posaconazole trough concentrations are not influenced by inflammation: A prospective study

open access: yesInternational Journal of Antimicrobial Agents, 2019
During inflammation, several cytochrome P450 enzymes are downregulated. Recently it was shown that voriconazole metabolism is reduced during inflammation. Posaconazole, another triazole with broad-spectrum antifungal activity, is metabolised only to a limited extent by cytochrome P450 enzymes and to a wider extent by phase 2 enzyme systems.
Märtson, Anne-Grete   +7 more
openaire   +2 more sources

Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma

open access: yesScientific Reports, 2023
The safety and effectiveness of pazopanib are related to plasma trough concentrations in renal cell carcinoma (RCC); however, data on pazopanib plasma trough concentrations with soft tissue sarcoma (STS) are limited.
Takeshi Aoyama   +16 more
doaj   +1 more source

Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2015
PURPOSE: Triple therapy for HCV-1 infection consists in boceprevir or telaprevir, ribavirin and PEG-interferon. Telaprevir is a P-glycoprotein substrate and it is metabolized by CYP3A4/5. No data have been published on intracellular penetration of telaprevir.
CUSATO, JESSICA   +8 more
openaire   +6 more sources

Clinical and genetic determinants of nevirapine plasma trough concentration [PDF]

open access: yesSAGE Open Medicine, 2018
Background: Only few data are available on the influence of CYP2B6 and CYP3A4/A5 polymorphisms on nevirapine plasma concentrations in the Caucasian population. Our aim was to assess the impact of CYP2B6 and CYP3A4/A5 polymorphisms on nevirapine plasma concentrations consecutively collected.
Giacomelli, Andrea   +12 more
openaire   +3 more sources

Factors affecting serum concentration of dabigatran in Asian patients with non-valvular atrial fibrillation

open access: yesJournal of the Formosan Medical Association, 2019
Background/purpose: Dabigatran is effective in preventing ischemic stroke and systemic embolism in patients with atrial fibrillation. Although the therapeutic window for dabigatran is wide, its pharmacokinetic properties can differ between specific ...
Shin-Yi Lin   +6 more
doaj   +1 more source

Combined Effect of CYP2C19 Genetic Polymorphisms and C-Reactive Protein on Voriconazole Exposure and Dosing in Immunocompromised Children

open access: yesFrontiers in Pediatrics, 2022
BackgroundPediatric patients have significant interindividual variability in voriconazole exposure. The aim of the study was to identify factors associated with voriconazole concentrations and dose requirements to achieve therapeutic concentrations in ...
Juan Chen   +5 more
doaj   +1 more source

The relationship of vancomycin 24-hour AUC and trough concentration

open access: yesAmerican Journal of Health-System Pharmacy, 2021
Abstract Purpose Prior to the 2020 release of a joint consensus guideline on monitoring of vancomycin therapy for serious methicillin-resistant Staphylococcus aureus (MRSA) infections, clinicians had escalated vancomycin doses for 2 decades while targeting trough concentrations of 15 to 20 µg/mL ...
David E Nix   +2 more
openaire   +2 more sources

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy